pharmaphorum

JUNE 1, 2022

Practical examples of this include healthcare professionals using VR to learn various medical procedures or for the technology to be used to teach broader society about public health issues, such as the importance of vaccination. When both ‘treatments’ were combined, the vaccination intention increased even further. The more you know.

Vaccines 145

Vaccines Immunization Immunity Hospitals 145

European Pharmaceutical Review

NOVEMBER 23, 2023

Boehringer Ingelheim is acquiring Swiss biotech T3 Pharmaceuticals AG (T3 Pharma), for up to £406 million (450 million CHF), boosting its immuno-oncology portfolio. Overall, the process enables the design of immuno-oncology combination therapies in one single agent.

Immunization 115

Immunization Immunity Pharmaceutical Companies Pharmaceutical Companies 115

European Pharmaceutical Review

DECEMBER 12, 2023

He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer.

Immunization 124

Immunization Immunity Chemotherapy Pharmaceutical Companies 124

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Coronavirus vaccine components. The vaccine also contains other inactive ingredients such as cholesterol.

Vaccines 52

Vaccines Immunization Immunity Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Flavivirus vaccine components. Sanofi is one of the leading patent filers for Flavivirus vaccine components.

Vaccines 52

Vaccines Immunization Immunity Pharmaceutical Companies 52

pharmaphorum

AUGUST 27, 2020

Over the past five to ten years US investors have focused on technology and internet companies, and relatively little on new biotech or pharmaceutical companies. As a result, the FTSE 350 Pharmaceuticals & Biotech index hit all-time highs in May. Investment trends in the US influence investor appetite in the UK.

Vaccines 122

Vaccines Drug Pricing Compounding Immunity 122

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

PharmaShots

APRIL 25, 2023

Numerous pharmaceutical companies have developed and authorized vaccines to provide immunity against COVID-19. Despite the drenched market of covid products, many other drugs have set an impressive benchmark for pharmaceutical companies in 2021. Watch out for the full report on Dupixent tomorrow. Stay tuned!

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunization 56

NY Times

NOVEMBER 10, 2021

The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunity 52

pharmaphorum

NOVEMBER 2, 2020

The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement the most cutting-edge technologies. With COVID-19 dominating people’s concerns, more sophisticated tech could lead us towards a vaccine or cure.

Vaccines 132

Vaccines Drug Development Diabetes Immunization 132

pharmaphorum

NOVEMBER 4, 2022

BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate a single dose mRNA-based combination vaccine candidate against influenza and COVID-19 – a novel combination approach to help protect individuals against two severe respiratory viral diseases in one dose.

Vaccines 52

Vaccines Immunization Immunity Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 8, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Vaccines 96

Vaccines Immunization Immunity Pharmaceutical Companies 96

pharmaphorum

OCTOBER 12, 2022

Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Similar to how we injected mRNA into people to trigger an immune response and train their immune system against COVID-19, genomic medicine repairs cellular or molecular mechanisms that are dysfunctional and cause disease.”.

Drug Development 105

Drug Development Immunization Immunity Vaccines 105

Pharmaceutical Technology

APRIL 18, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Mayo Clinic 59

Mayo Clinic Immunization Immunity Vaccines 59

Pharmaceutical Technology

MARCH 9, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Immunization 52

Immunization Immunity Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Immunization 52

Immunization Immunity Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 26, 2008

It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 40

Pharmaceutical Technology

MAY 15, 2023

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. The company has an operational presence in the US and the UK (headquartered in Abingdon, Oxfordshire, UK).

Adverse Reactions 52

Adverse Reactions Mayo Clinic Immunization Immunity 52

Pharmaceutical Technology

MAY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Immunization 52

Immunization Immunity Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Immunization 52

Immunization Immunity Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Diabetes 52

Diabetes Hospitals Immunization Immunity 52

NY Times

JUNE 2, 2021

We need more vaccines, fast. Is forcing pharmaceutical companies to share their intellectual property the answer?

Vaccines 55

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunity 55

Express Pharma

APRIL 16, 2024

As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most. It also contributes to 40 per cent of medications in the US and 33 per cent in the EU.

Vaccines 105

Vaccines Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

JULY 30, 2021

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health literacy has never been more important. Again, vaccine hesitancy is probably the most obvious example here.

Vaccines 119

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 119

pharmaphorum

AUGUST 13, 2020

To take one local example, in the UK Pfizer is working with the National Schools Partnership to make its Superbugs and Vaccines education program suitable for home learning. Pfizer has four different mRNA platform vaccines in play against one-another: a radical new approach for them.

Health and Personal Care Stores 112

Health and Personal Care Stores Vaccines Communication Diabetes 112

Pharmaceutical Technology

MAY 8, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Vaccines 59

Vaccines Immunization Immunity Pharmaceutical Companies 59

PharmaShots

MARCH 9, 2023

In 2016, she received a special career-recognition award from Fundamed Foundation (a non-profit Spanish foundation) in the category of the most influential pharmaceutical executive from Spain over the past 15 years Education: Belén is an alumnus of the University of Alcala de Henares as an MS, Ph.D., LinkedIn Total experience: 26 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

PharmaShots

MAY 23, 2023

Was ranked the highest among the list of companies developing Cell & Gene therapy, followed by Novartis with a revenue of $50.54B and Spark Therapeutics with a revenue of $49.27B PharmaShots brings an informative report on the Top 20 Cell and Gene Therapy Companies based on the total Revenue generated in the year 2022 Total Revenue: $0.5M

Diabetes 58

Diabetes Immunity Immunization Pharmaceutical Companies 58

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies have been working on developing vaccines and other prophylactics for respiratory syncytial virus (RSV) since its discovery in 1956. Despite strong efforts and scientific advances, a safe and effective vaccine for RSV has yet to be approved for any patient population.

Vaccines 64

Vaccines Documentation Immunization Immunity 64

PharmaShots

FEBRUARY 21, 2023

Other radiotherapies under the company's pipeline include Humalutin and Alpha37. Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. The company is evaluating Iomab-B in a P-III clinical trial (SIERRA) in patients with relapsed or refractory acute myeloid leukemia (AML).

Dosage 56

Dosage Labelling Immunity Immunization 56

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May.

Vaccines 52

Vaccines Nursing Homes Communication Pharmaceutical Companies 52

European Pharmaceutical Review

AUGUST 29, 2024

5 Preventing spread of the mpox virus To help prevent more cases of the virus, the CDC recommended that individuals who have had exposure to the virus and those at risk of infection are given two doses of biotech Bavarian Nordic’s vaccine JYNNEOS ® (MVA-BN).

Vaccines 98

Vaccines Immunity Immunization Pharmaceutical Companies 98

Pharmaceutical Technology

APRIL 24, 2023

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures. As a result, some pharmaceutical companies are turning to third parties.

Vaccines 52

Vaccines Compounding Communication Immunity 52